• Team size: Marketing Team 15 people and Sales Teams ~240 people, full P&L responsibility ~400 Mil RMB revenues• Sales Result: Rebuilt the sales team with expansion of 80 HC and ensured full compliance. Achieved highest market share for both Clenil and Foster in 2021 and 2022 since taking back from Edding Pharm. Achieved 130% sales target by end 2022• Product Launch: Developed new product launch strategy for Trimbow and optimized human resources by defining territory for Chiesi team and alliance partners to maximize return• NRDL: Prepared new product NRDL inclusion and received approval in Q1 2023• Alliance: Co-promoted with local CSO and Bayer to penetrate broad market for ICS nebulization in China

(Collaborating with other two seasoned investors, Eight Roads and F-Prime Capital, on new incubation projects) • Played a lead role in the ongoing projects including market analysis, asset screening, and business development. (The incubation company set up in April 2021 with secured A round financing)

• Team size: Medical Team 4 people, Marketing Team 6 people, Dedicated Sales Team 5 provinces ~50 people, Other provinces Contracted Sales Team ~650 people• Market Access: Achieved 17 provincial market access and 160 class III & class II HP listing in 6 months• Strategy: Initiated consensus and local guideline engagement; set up marketing and medical strategy to maximize product line (more than 20 products) competitiveness and support CSO team to quickly understand inhalation product promotion model• Cross Function: Worked with R&D to optimize portfolio strategy and market access dossier • Marketing: Built Joincare company brand awareness in the respiratory and paediatric areas by implementing multichannel marketing and KOL engagement

• Team size: ~420 people (8 RSMs, 8 Field Promotion Manager, 51 DSMs)• Market Access: Looked after whole product lines, including two new launch products and three established products, and drive hospital listing and sales achievement across brands• Market Access: Developed strategy with marketing team and distributor team to overcome Jiangsu and Henan price negotiation issues

• Team: Marketing 3 people and sales team 191 people (3 RSMs, 1 Field Promotion Manager, 23 DSMs). Target market potential: RMB 6 Billion • Strategy: Optimized pediatric portfolio strategy in order to maximize current products’ revenue and speed up listing progress (27 HP listed since Mar 2018)• Low Tier Market: Negotiated with third party to penetrate low tier clinics and hospitals, which accelerated nebulization product sales growth

• Team size: ~240 people (4 RSMs, 4 Field Promotion Manager, 26 DSMs); Responsible business size: RMB 260M• Growth: Drove performance by setting direction and turned the business from negative to positive growth in 2016 and achieved 7% value growth (around 3.5% price cut) in 2017• Sales Result: Developed team’s capabilities on finding market opportunities, solving problems, and closing sales, which resulted in market share gain from AZ Symbicort in ICS/LABA market by 3% and SOV increase from 34% to 47%(2016 Q1 vs Q4

• Launch Strategy: Responsible for new product global launch and set up “open triple” combination therapy promotion strategy• Marketing: Developed treatment evolution campaign in order to create sense of urgency amongst HCPs addressing the under-treatment of many COPD patients• Communication: Collaborated with country launch leads to ensure all campaigns are aligned with corporate strategy and to achieve launch ambition

• Leadership: Maintained team morale during the GSK crisis and motivated team members by facilitating continuous caring and open discussions with subordinates and setting clear short-term goals to reduce uncertainty • Cross Function: Worked across functions to prepare product launch, such as optimizing hospital listing and bidding strategy with Key Account team, developing recruitment strategy with HR for DSM and medical representative, and supporting Market Access team on national reimbursement project

• Launch Strategy: Employed need assessments with different countries to customize LatAm and Asia Pacific workshops in order to help regions find real growth opportunities and implement launch optimization• Communication: Implemented launch readiness check with Russia, Turkey, and Mexico to optimize launch preparation

• Marketing: Enhanced and implemented cross-national hospital talk campaign (110% achievement and >25% growth in 200 strategic hospitals), which was recognized with 2012 Emerging Market CEO Award

Initiated Google Adwords campaign promoting company’s bioinformatics software, which increased web traffic by 25%